Precision Spine earns FDA clearance for ShurFit ACIF 2C system: 5 points Featured

Written by  Megan Wood | Thursday, 19 January 2017 20:22
Social sharing

Parsippany, N.J.-based Precision Spine received FDA clearance for its ShurFit ACIF 2C anterior cervical interbody system.

Here are five points:


1. Composed of medical grade polyetheretherketone, the system is coated with titanium and hydroxyapatite.


2. The biomaterial combination is designed to offer an enhanced solution for achieving biologic fusion.


3. The system's coating promotes bony growth while the large graft maximizes vertebral body support and reduces subsidence risk.


4. The ShurFit features a trapezoidal design that helps with anterior placement; a tooth patter which subdues implant expulsion; and tantalum markers intended to facilitate radiographic implant positioning.


5. Patients suffering from degenerative disc disease in their cervical spines are ideal candidates for treatment with the ShurFit.


More articles on devices:
Zimmer Biomet names new President, Americas: Robert Delp — 5 key notes
Global biomaterials market to grow at 16% CAGR through 2021: 7 observations
VEXIM records $5.6M in Q4 2016 sales; gains momentum in spine trauma market — 8 highlights

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months